MiROvaR, a microRNA-based predictor of early relapse for ovarian cancer patients [validation set; OC133]
Ontology highlight
ABSTRACT: Despite a pathological complete response, risk-of-relapse remains a challenge for most of epithelial ovarian cancer (EOC) patients and an ad-hoc predictor can be a valuable clinical tool. We developed a 35 miRNAs-based predictor of Risk of Ovarian Cancer Relapse (MiROvaR) using a training set of patients from MITO-2 (Multicentre Italian Trials in Ovarian Cancer-2; Pignata S et al. J Clin Oncol. 2011 Sep 20). MiROvaR performance was confirmed in two independent validation cohorts.
ORGANISM(S): Homo sapiens
PROVIDER: GSE73582 | GEO | 2016/10/31
SECONDARY ACCESSION(S): PRJNA297361
REPOSITORIES: GEO
ACCESS DATA